Pascal Juillerat MD MSc, IBD specialist retweeted
Great lucter abt Acute Severe & Fulminant Colitis by @PascalJuillerat
Masterclass in IBD 💚
supervised by @DignassAxel & Stephan Vavricka
@my_ueg EDUCATION 💙
Vienna 🎡 2025
#UEG 💜 #IBD #UC #ASCU
. – at Vienna, Austria
Pascal Juillerat MD MSc, IBD specialist retweeted
🤩 exciting days ahead
Replying to @my_ueg
Course Directors: @DignassAxel, @VavrickaStephan
Faculty: @ign76, @Bealoquebea, @DrAilsaHart, @PascalJuillerat, Bel Klaartje Kok, James Lindsay, @PMyrelid, @edyta_tul, @bverstockt
Pascal Juillerat MD MSc, IBD specialist retweeted
Great talk by Bel Kok regarding disease monitoring in IBD at @my_ueg IBD masterclass
Pascal Juillerat MD MSc, IBD specialist retweeted
Course Directors: @DignassAxel, @VavrickaStephan
Faculty: @ign76, @Bealoquebea, @DrAilsaHart, @PascalJuillerat, Bel Klaartje Kok, James Lindsay, @PMyrelid, @edyta_tul, @bverstockt
Pascal Juillerat MD MSc, IBD specialist retweeted
AGA 2025 clinical practice guidelines for Crohn’s disease 📌🆕
📸: gastrojournal.org/action/sho…
Pascal Juillerat MD MSc, IBD specialist retweeted
'Free to read' via bit.ly/45GWWRG
"Global Consensus Statement on the Management of Pregnancy in Inflammatory Bowel Disease"
by Mahadevan et al
#IBD #GItwitter #pregnancy
Pascal Juillerat MD MSc, IBD specialist retweeted
We’re pleased to announce the “ECCO-ESGAR-ESP-IBUS Guideline on Diagnostics and Monitoring of Patients with IBD,” a project involving IBUS, showing the role of IUS in the diagnosis and monitoring of IBD patients.
P.1: 10.1093/ecco-jcc/jjaf106
P.2: 10.1093/ecco-jcc/jjaf107
Pascal Juillerat MD MSc, IBD specialist retweeted
Appendicectomy plus standard medical therapy versus standard medical therapy alone for maintenance of remission in ulcerative colitis (ACCURE): a pragmatic, open-label, international, randomised trial - The Lancet Gastroenterology & Hepatology thelancet.com/journals/langa…
Pascal Juillerat MD MSc, IBD specialist retweeted
Just Starting 4th Postgraduate Course #ECCO2025 #EDUCOM course with more than 350 attendees!
@UriKopylov @FernandoMagro6 with and a amazing talk from @SeverineVermei1
Thank you for your contribution to this Great case discussion and long Life to the PG of ECCO ! @manu_barreiro @Iagorlago @UriKopylov #ECCO2025
Postgraduate course #ECCO2025 very interesting clinical case discussion!
@Iagorlago @PascalJuillerat
Pascal Juillerat MD MSc, IBD specialist retweeted
Mucosal Healing With Vedolizumab in Patients With Chronic Pouchitis: EARNEST, a Randomized, Double-Blind, Placebo-Controlled Trial ➡️ ow.ly/qY1950UX0ZO
Pascal Juillerat MD MSc, IBD specialist retweeted
Just published in the American Journal of Therapeutics 🔥
JAKi in Chronic Inflammatory Pouch Conditions:
📌Clinical response: 43%
📌Endoscopic response: 48%
📌AEs: 16%
📌Primary treatment failure: 42%
📊JAKi are not recommended to be first line treatment in chronic pouch conditions ✔️
@JHashashMD @fouadsjaber @YazanAbboudMD @CrohnsColitisFn #GITwitter #IBD @MondayNightIBD
Completely agree ! Amazing meeting and conclusions, congratulations! @EdwardLoftus2 @MLongMD @MRegueiroMD @DrCoreySiegel @NMH_SHanauerMD #AIBD2024
Pascal Juillerat MD MSc, IBD specialist retweeted
How can you not love Charles Bernstein ? Amazing career as a clinician scientist for over 30 years!!! Linking the learnings from IBD epidemiology to climate inform clinical practice @gilkaplan @EdwardLoftus2
Pascal Juillerat MD MSc, IBD specialist retweeted
#ECCO UC Treatment Guideline Update - how it started...
@bverstockt @HolubarStefan @RajaAtreya @I_Blumenstein @AlaaEl_Hussuna @manu_barreiro @AnthonydeBuck @fgomollon @Max_Fantini @fede__furfaro @MariangelaAllo3 @PascalJuillerat @mjosecasanova @UriKopylov @EderPiotr et al.
#IBD
Pascal Juillerat MD MSc, IBD specialist retweeted
IBD Monitoring how&when. Tandem talk with #HagarBanaiEran from #rabinhospitalpetahtikva at #FalkSymposium238 in Florence. @HUNIMED
Luc Biedermann at #Falksymposium238 presenting on biological treatments in EoE. @IBD_USZ , Great job.
Pascal Juillerat MD MSc, IBD specialist retweeted
🌟 Making a choice of therapy for IBD
Take into account extraintestinal concerns as well as contraindications to treatment!
🙏🏻 @IBDMD
#GITwitter #ACG2024 @AmCollegeGastro
Pascal Juillerat MD MSc, IBD specialist retweeted
Nobel Prize winning concepts land in IBD. The discovery of power and importance of microRNA biology . @bruce_sands1 presenting the long term results of the phase 2a Obefazimod UC. Study . Is this the game changer? Calling all investigators . We need to get the phase III DONE !!!

























































